Related Experiment Video
Updated: Aug 7, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Sarcoma of the Breast: A Rare and Heterogeneous Entity
Shoshana T Levi1, Heather A Lillemoe2
1Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
None:
Breast sarcomas are a rare and pathologically diverse group of malignancies. They can arise de novo or in a previously irradiated field and tend to have poor prognostic outcomes. Given their rarity and the tendency to combine the various histologies in single analyses, data related to management and prognostic outcomes are somewhat limited. Surgical resection remains the mainstay of treatment with the intention for wide-margin resection, except in the case of radiation-associated angiosarcoma, where radical resection is associated with improved local control. Multidisciplinary treatment is common and is ideally undertaken at a high-volume sarcoma center to optimize outcomes.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
